1. Home
  2. YSG vs TOVX Comparison

YSG vs TOVX Comparison

Compare YSG & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSG
  • TOVX
  • Stock Information
  • Founded
  • YSG 2016
  • TOVX 2001
  • Country
  • YSG China
  • TOVX United States
  • Employees
  • YSG N/A
  • TOVX N/A
  • Industry
  • YSG Package Goods/Cosmetics
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSG Consumer Discretionary
  • TOVX Health Care
  • Exchange
  • YSG Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • YSG 889.0M
  • TOVX 3.8M
  • IPO Year
  • YSG 2020
  • TOVX 2006
  • Fundamental
  • Price
  • YSG $6.50
  • TOVX $0.28
  • Analyst Decision
  • YSG
  • TOVX Hold
  • Analyst Count
  • YSG 0
  • TOVX 1
  • Target Price
  • YSG N/A
  • TOVX N/A
  • AVG Volume (30 Days)
  • YSG 230.9K
  • TOVX 44.2M
  • Earning Date
  • YSG 11-20-2025
  • TOVX 11-11-2025
  • Dividend Yield
  • YSG N/A
  • TOVX N/A
  • EPS Growth
  • YSG N/A
  • TOVX N/A
  • EPS
  • YSG N/A
  • TOVX N/A
  • Revenue
  • YSG $522,879,337.00
  • TOVX N/A
  • Revenue This Year
  • YSG $24.18
  • TOVX N/A
  • Revenue Next Year
  • YSG $14.76
  • TOVX N/A
  • P/E Ratio
  • YSG N/A
  • TOVX N/A
  • Revenue Growth
  • YSG 11.53
  • TOVX N/A
  • 52 Week Low
  • YSG $3.01
  • TOVX $0.26
  • 52 Week High
  • YSG $11.57
  • TOVX $2.22
  • Technical
  • Relative Strength Index (RSI)
  • YSG 33.12
  • TOVX 40.94
  • Support Level
  • YSG $6.33
  • TOVX $0.29
  • Resistance Level
  • YSG $6.98
  • TOVX $0.33
  • Average True Range (ATR)
  • YSG 0.41
  • TOVX 0.07
  • MACD
  • YSG -0.07
  • TOVX -0.01
  • Stochastic Oscillator
  • YSG 6.21
  • TOVX 2.23

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: